Thursday, May 15, 2014
Publication and contact
Fibroblast growth factor 19 (FGF19);
growth factor receptor 4 (FGFR4;
Mouse studies suggest an
FGF19 variant that activates a subset of pathways downstream of FGFR4 could
help treat liver cancer. In mice, adeno-associated viral (AAV) vector-induced
expression of FGF19 variants showed that the M70 variant bound Fgfr4 but did
not induce tumor formation or activation of a tumor-associated signaling
pathway in liver cells. In mice, coexpression of FGF19 and the M70 variant
resulted in decreased tumor formation compared with expression of FGF19
alone, indicating that M70 can counter the known tumor-promoting activity of
wild-type FGF19. Next steps include evaluating M70 for clinical use in
primary biliary cirrhosis, hepatocellular carcinoma and nonalcoholic
Pharmaceuticals Inc. has ISIS-FGF4Rx,
an antisense oligonucleotide targeting FGFR4 mRNA, in Phase I testing
to treat obesity.
Medicines has BLU9931,
a small molecule inhibitor of FGFR4, in preclinical development to treat
Published online May 15, 2014
Patent applications filed;
available for licensing from NGM
Zhou, M. et al. Cancer
Res.; published online April 11, 2014;
Contact: Lei Ling, NGM Biopharmaceuticals Inc., South San
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]